SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-24-011282
Filing Date
2024-03-05
Accepted
2024-03-05 07:05:20
Documents
16
Period of Report
2024-02-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ef20023144_8k.htm   iXBRL 8-K 31901
2 EXHIBIT 99.1 ef20023144_ex99-1.htm EX-99.1 11601
6 image1.jpg GRAPHIC 29307
  Complete submission text file 0001140361-24-011282.txt   224640

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA rnac-20240228.xsd EX-101.SCH 3871
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE rnac-20240228_lab.xml EX-101.LAB 21966
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rnac-20240228_pre.xml EX-101.PRE 16048
17 EXTRACTED XBRL INSTANCE DOCUMENT ef20023144_8k_htm.xml XML 4069
Mailing Address 65 GROVE STREET WATERTOWN MA 02472
Business Address 65 GROVE STREET WATERTOWN MA 02472 617-923-1400
Cartesian Therapeutics, Inc. (Filer) CIK: 0001453687 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37798 | Film No.: 24718248
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)